The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...
Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...
FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 – glucagon-like peptide-1 receptor agonists – drugs, including semaglutide and tirzepatide, as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback